V010-3504 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

V010-3504 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine
V010-3504 Screening compound: 2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine alternative view

Chemical Structure Depiction of ChemDiv screening compound V010-3504
2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V010-3504

Molecular Formula

C22H20Cl2N6O (C22 H20 Cl2 N6 O)

Compound Name

2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

IUPAC name

2-(2-chlorophenyl)-4-(3-chlorophenyl)-N6-[(oxolan-2-yl)methyl]-2H-pyrazolo[34-d]pyrimidine-36-diamine

SMILES

Nc1c2c(-c3cc(Cl)ccc3)nc(NCC3OCCC3)nc2nn1-c(cccc1)c1Cl

InChI

InChI=1S/C22H20Cl2N6O/c23-14-6-3-5-13(11-14)19-18-20(25)30(17-9-2-1-8-16(17)24)29-21(18)28-22(27-19)26-12-15-7-4-10-31-15/h1-3,5-6,8-9,11,15H,4,7,10,12,25H2,(H,26,28,29)/t15-/m1/s1

InChI Key

XRZFKIOPPRWIRT-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD14249239

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

455.35

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.808

Distribution Coefficient, logD

4.808

Water Solubility, LogSw

-5.02

Polar Surface Area

73.164

Acid Dissociation Constant (pKa)

18.25

Base Dissociation Constant (pKb)

3.81

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

22.70

V010-3504 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V010-3504 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V010-3504?
Check Price and Availability of V010-3504, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V010-3504 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V010-3504
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V010-3504
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V010-3504 available by request